IL146298A0 - Cyclothiocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclothiocarbamate derivatives as progesterone receptor modulators

Info

Publication number
IL146298A0
IL146298A0 IL14629800A IL14629800A IL146298A0 IL 146298 A0 IL146298 A0 IL 146298A0 IL 14629800 A IL14629800 A IL 14629800A IL 14629800 A IL14629800 A IL 14629800A IL 146298 A0 IL146298 A0 IL 146298A0
Authority
IL
Israel
Prior art keywords
alkyl
optionally substituted
aryl
ring
groups
Prior art date
Application number
IL14629800A
Other languages
English (en)
Original Assignee
American Home Prod
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by American Home Prod, Ligand Pharm Inc filed Critical American Home Prod
Publication of IL146298A0 publication Critical patent/IL146298A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14629800A 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators IL146298A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011749 WO2000066570A1 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
IL146298A0 true IL146298A0 (en) 2002-07-25

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14629800A IL146298A0 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Country Status (24)

Country Link
EP (1) EP1175411B1 (xx)
JP (2) JP4958338B2 (xx)
KR (1) KR100732692B1 (xx)
CN (1) CN1131856C (xx)
AT (1) ATE386729T1 (xx)
AU (1) AU766801B2 (xx)
BG (1) BG65277B1 (xx)
BR (1) BR0010214A (xx)
CA (1) CA2371712C (xx)
CZ (1) CZ20013952A3 (xx)
DE (1) DE60038108T2 (xx)
DK (1) DK1175411T3 (xx)
EA (1) EA004511B1 (xx)
ES (1) ES2301482T3 (xx)
GE (1) GEP20043181B (xx)
HU (1) HUP0203332A3 (xx)
IL (1) IL146298A0 (xx)
MX (1) MXPA01011287A (xx)
NO (1) NO321370B1 (xx)
NZ (1) NZ515353A (xx)
PL (1) PL351083A1 (xx)
SG (1) SG120970A1 (xx)
SK (1) SK15922001A3 (xx)
TR (1) TR200103285T2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
NZ515353A (en) * 1999-05-04 2004-03-26 Ligand Pharm Inc Cyclothiocarbamate derivatives as progesterone receptor modulators
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
ATE409699T1 (de) * 2004-04-08 2008-10-15 Wyeth Corp Verfahren zur minimierung von thioamidverunreinigungen
AU2005238520B2 (en) * 2004-04-27 2011-09-08 Wyeth Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
AU2005237520B2 (en) 2004-04-27 2012-01-19 Wyeth Purification of progesterone receptor modulators
WO2006014476A1 (en) * 2004-07-07 2006-02-09 Wyeth Cyclic progestin regimens and kits
ATE541853T1 (de) 2004-08-13 2012-02-15 Wyeth Llc Tanaproget-derivate, metaboliten und verwendungen dafür
EP1874278B1 (en) 2005-04-28 2009-06-24 Wyeth Compositions containing micronized tanaproget
ATE460937T1 (de) * 2005-04-28 2010-04-15 Wyeth Corp Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung
MX2007013467A (es) * 2005-04-28 2008-01-21 Wyeth Corp Tanaproget micronizado y composiciones que contienen el mismo.
BRPI0610433A2 (pt) * 2005-04-28 2010-11-23 Wyeth Corp forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada
PE20061322A1 (es) * 2005-04-28 2006-12-28 Wyeth Corp Forma purificada de tanaproget
TW200716137A (en) * 2005-06-09 2007-05-01 Wyeth Corp Tanaproget compositions containing ethinyl estradiol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
DK0800519T3 (da) * 1994-12-22 2004-03-01 Ligand Pharm Inc Steroidreceptormodulatorforbindelser og fremgangsmåder
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
ATE248826T1 (de) * 1996-10-02 2003-09-15 Bristol Myers Squibb Pharma Co 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv- reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
NZ515353A (en) * 1999-05-04 2004-03-26 Ligand Pharm Inc Cyclothiocarbamate derivatives as progesterone receptor modulators
MX2007013467A (es) * 2005-04-28 2008-01-21 Wyeth Corp Tanaproget micronizado y composiciones que contienen el mismo.
TW200716137A (en) * 2005-06-09 2007-05-01 Wyeth Corp Tanaproget compositions containing ethinyl estradiol

Also Published As

Publication number Publication date
KR100732692B1 (ko) 2007-06-27
JP2012087129A (ja) 2012-05-10
CA2371712C (en) 2009-12-22
EP1175411B1 (en) 2008-02-20
HUP0203332A3 (en) 2004-12-28
NO20015381L (no) 2002-01-03
GEP20043181B (en) 2004-02-25
JP4958338B2 (ja) 2012-06-20
DE60038108T2 (de) 2009-02-12
AU766801B2 (en) 2003-10-23
NO321370B1 (no) 2006-05-02
MXPA01011287A (es) 2003-07-14
ATE386729T1 (de) 2008-03-15
EA004511B1 (ru) 2004-04-29
TR200103285T2 (tr) 2002-02-21
NZ515353A (en) 2004-03-26
DK1175411T3 (da) 2008-06-09
SK15922001A3 (sk) 2002-09-10
JP2002543192A (ja) 2002-12-17
CN1349516A (zh) 2002-05-15
PL351083A1 (en) 2003-03-10
EP1175411A1 (en) 2002-01-30
KR20020000170A (ko) 2002-01-04
CN1131856C (zh) 2003-12-24
CZ20013952A3 (cs) 2002-05-15
HUP0203332A2 (hu) 2003-01-28
AU4811900A (en) 2000-11-17
EA200101181A1 (ru) 2002-04-25
ES2301482T3 (es) 2008-07-01
NO20015381D0 (no) 2001-11-02
DE60038108D1 (de) 2008-04-03
JP5523430B2 (ja) 2014-06-18
BG106080A (en) 2002-05-31
SG120970A1 (en) 2006-04-26
BG65277B1 (bg) 2007-11-30
BR0010214A (pt) 2002-02-13
CA2371712A1 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
PL351083A1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
BR0109855A (pt) Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5
MY118109A (en) Novel aralkyl amines of spirofuropyridines useful in therapy
HUP0301069A2 (hu) Új biaril-karboxamidok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP9801688A2 (hu) Acetamidszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
NO994452D0 (no) Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse
HUP0003073A2 (hu) Benzolszulfonamid-származékok, eljárás előállításukra és gyógyszerként való alkalmazásuk
ATE204269T1 (de) Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
AR007440A1 (es) Compuestos triciclos fenilamino sustituidos y composiciones farmaceuticas de los mismos.
BR0014901A (pt) Derivados de trifenil-alquenos e seu uso como moduladores de receptores seletivos de estrogênios
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
HUP9901096A2 (hu) Indolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
EE03872B1 (et) Arüülglütsiinamiidi derivaadid, meetod nende valmistamiseks ja neid ühendeid sisaldavad farmatseutilised preparaadid
HUP0402640A2 (hu) Indolilalkilamin-származékok 5-hidroxitriptamin-6 ligandumokként, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
FI894061A (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
ZA988668B (en) Novel 5-membered ring heterocycles their preparation their use and pharmaceutical preparations comprising them
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
HUP0301030A2 (hu) Kardiális aritmiák kezelésére alkalmazható új aza-biciklooktán-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NZ336189A (en) Diaza-spiro[3,5]nonane derivatives and use in treatment of diseases related to the orphanin receptor
HUP0101469A2 (hu) 5-[(2-Imidazolidinilidén)-amino]-benzimidazol-származékok, előállításuk és alkalmazásuk javított metabolikus stabilitású alfa-adrenoceptor agonistákként
TW334425B (en) Annelated dihydropyridines for preparing pharmaceutical preparations
NZ515355A (en) Cyclocarbamate derivatives as progesterone receptor modulators